104 related articles for article (PubMed ID: 16707393)
1. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.
Brannan JD; Gulliksson M; Anderson SD; Chew N; Seale JP; Kumlin M
Eur Respir J; 2006 May; 27(5):944-50. PubMed ID: 16707393
[TBL] [Abstract][Full Text] [Related]
2. Evidence of mast cell activation and leukotriene release after mannitol inhalation.
Brannan JD; Gulliksson M; Anderson SD; Chew N; Kumlin M
Eur Respir J; 2003 Sep; 22(3):491-6. PubMed ID: 14516140
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of refractoriness and mast cell mediator release following mannitol-induced bronchoconstriction.
Larsson J; Perry CP; Anderson SD; Brannan JD; Dahlén SE; Dahlén B
J Appl Physiol (1985); 2011 Apr; 110(4):1029-35. PubMed ID: 21252215
[TBL] [Abstract][Full Text] [Related]
4. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
Misso NL; Aggarwal S; Thompson PJ; Vally H
Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
[TBL] [Abstract][Full Text] [Related]
5. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
Anderson SD; Brannan JD; Perry CP; Caillaud C; Seale JP
J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
[TBL] [Abstract][Full Text] [Related]
6. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells.
Gulliksson M; Palmberg L; Nilsson G; Ahlstedt S; Kumlin M
Allergy; 2006 Dec; 61(12):1473-9. PubMed ID: 17073880
[TBL] [Abstract][Full Text] [Related]
7. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S
Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
[TBL] [Abstract][Full Text] [Related]
8. A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes.
Simpson AJ; Bood JR; Anderson SD; Romer LM; Dahlén B; Dahlén SE; Kippelen P
J Appl Physiol (1985); 2016 May; 120(9):1011-7. PubMed ID: 26846550
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction.
Kippelen P; Larsson J; Anderson SD; Brannan JD; Delin I; Dahlen B; Dahlen SE
Med Sci Sports Exerc; 2010 Feb; 42(2):273-80. PubMed ID: 19927031
[TBL] [Abstract][Full Text] [Related]
10. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
[TBL] [Abstract][Full Text] [Related]
11. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
[TBL] [Abstract][Full Text] [Related]
12. Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.
Briffa PJ; Anderson SD; Burton DL; Young IH
Respirology; 2011 Jan; 16(1):161-6. PubMed ID: 21054671
[TBL] [Abstract][Full Text] [Related]
13. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
Okayama Y; Church MK
Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.
Shin TR; Kim JH; Kim CH; Hyun IG; Choi JH
J Thorac Dis; 2015 Jul; 7(7):1198-204. PubMed ID: 26380736
[TBL] [Abstract][Full Text] [Related]
16. Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine.
Ketchell RI; Jensen MW; Spina D; O'Connor BJ
Eur Respir J; 2002 Apr; 19(4):611-6. PubMed ID: 11998988
[TBL] [Abstract][Full Text] [Related]
17. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
Bochenek G; Nizankowska E; Gielicz A; Swierczyńska M; Szczeklik A
Thorax; 2004 Jun; 59(6):459-64. PubMed ID: 15170023
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction.
Storm van's Gravesande K; Mattes J; Grossklauss E; Zurmühl A; Moseler M; Kühr J
Eur J Pediatr; 2000 Oct; 159(10):759-63. PubMed ID: 11039131
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management.
Cowan DC; Hewitt RS; Cowan JO; Palmay R; Williamson A; Lucas SJ; Murrell CJ; Thomas KN; Taylor DR
Respirology; 2010 May; 15(4):683-90. PubMed ID: 20337988
[TBL] [Abstract][Full Text] [Related]
20. Leptin and urinary leukotriene E4 and 9α,11β-prostaglandin F2 release after exercise challenge.
Baek HS; Choi JH; Oh JW; Lee HB
Ann Allergy Asthma Immunol; 2013 Aug; 111(2):112-7. PubMed ID: 23886229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
